• No results found

18 results with keyword: 'physiopathology cell acute lymphoblastic leukemia focus molecular aspects'

The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on

Protected

N/A

11
0
0
2021
Offshore Wind Farm Layouts

Figure 65 - Star design, DC transmission, worst case operating conditions ... Maximum speed deviation [pu on system base] and voltage deviation [% of initial value] ) of the

Protected

N/A

239
0
0
2021
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China

ALL: Acute lymphoblastic leukemia; T-ALL: T-cell acute lymphoblastic leukemia; B-ALL: B-cell acute lymphoblastic leukemia; MRD: Minimal residual disease; PR: Prednisone response;

Protected

N/A

11
0
0
2020
Steroid response as prognostic factor and its correlation with molecular assessment of childhood acute lymphoblastic leukemia

Steroid response as prognostic factor and its correlation with molecular assessment of childhood acute lymphoblastic leukemia.. Keywords: acute lymphoblastic leukemia,

Protected

N/A

6
0
0
2020
Protein kinase inhibitors for acute leukemia

ALL: Acute lymphoblastic leukemia; AML: Acute myelocytic leukemia; BCP- ALL: B-cell precursor acute lymphoblastic leukemia; BLK: B lymphocyte kinase; BTK: Bruton ’ s tyrosine

Protected

N/A

7
0
0
2020
Pediatric T-Cell Acute Lymphoblastic Leukemia

Precursor T-cell lymphoblastic leukemia; T-cell acute lymphoblastic leukemia; T-cell ALL; T-ALL; T-cell receptor; thymocyte; transcription factor.. Clinics

Protected

N/A

14
0
0
2021
MYC as therapeutic target in leukemia and lymphoma

leukemia; pre T-LBL, precursor T-cell lymphoblastic leukemia/lymphoma; AML, acute myeloid leukemia; DLBCL, diffuse large B-cell lymphoma; ALL, acute lymphocytic leukemia; T-ALL,

Protected

N/A

17
0
0
2020
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations

HSCT, hematopoietic stem-cell transplantation; Acute leukemia, acute myeloid leukemia (36%); acute lymphoblastic leukemia (24%); myelodysplastic syndrome (30%); other (10%);

Protected

N/A

8
0
0
2021
Childhood pre B cell acute lymphoblastic leukemia with translocation t(1;19)(q21 1;p13 3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report

ACAs: Additional cytogenetic abnormalities; ALL: Acute lymphoblastic leukemia; aMCB: Array-proven high-resolution multicolor banding; B-ALL: B cell acute lymphoblastic leukemia;

Protected

N/A

6
0
0
2020
T cell receptor gamma and delta rearrangements in hematologic malignancies  Relationship to lymphoid differentiation

T cell receptor delta gene recombinatorial events were found in 91% of acute T cell lymphoblastic leukemia, 68% of non-T, non-B lymphoid precursor acute.. lymphoblastic leukemia

Protected

N/A

12
0
0
2020
Single-cell analysis of tumors: Creating new value for molecular biomarker discovery of cancer stem cells and tumor-infiltrating immune cells.

ALL: Acute lymphoblastic leukemia; AML: Acute myeloid leukemia; ccRCC: Clear cell renal cell carcinoma; CML: Chronic myeloid leukemia; CNV: Copy number variant; CSC: Cancer stem

Protected

N/A

13
0
0
2021
Adverse Childhood Experiences International Questionnaire (ACE-IQ)

These next questions are about how often, when you were a child, YOU may have seen or heard certain things in your NEIGHBOURHOOD OR COMMUNITY (not in your home or on TV, movies,

Protected

N/A

5
0
0
2021
Mutational spectrum of adult T-ALL

subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)

Protected

N/A

13
0
0
2020
Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation

Alb, albumin; ALL, acute lymphoblastic leukemia; allo-SCT, allogeneic stem cell transplantation; ALT, alanine aminotransferase; AML, acute myelogenous leukemia; ANKL, aggressive NK

Protected

N/A

7
0
0
2020
Immunotherapy in hematologic malignancies: past, present, and future

ALL: Acute lymphoblastic leukemia; AML: Acute myeloid leukemia; BAFF: B cell-activating factor; BCMA: B cell maturation antigen; BiKE: Bispecific NK cell engager; BiTE: Bispecific

Protected

N/A

10
0
0
2020
Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies

Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; DLBCL, diffuse large B-cell

Protected

N/A

10
0
0
2020
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia

ADCC: Antibody-dependent cell-mediated cytotoxicity; ALL: Acute lymphoblastic leukemia; allo-HSCT: Hematopoietic stem cell transplantation; AML: Acute myeloid leukemia; ATRA:

Protected

N/A

14
0
0
2020
Development of leukemia in donor cells after allogeneic stem cell transplantation  a survey of the European Group for Blood and Marrow Transplantation (EBMT)

Characteristics of donor cell leukemia/myelodysplasia Of the 14 cases of donor cell leukemia / myelodys- plasia, seven were acute myeloid leukemia (AML), three were acute

Protected

N/A

7
0
0
2020

Upload more documents and download any material studies right away!